SB

Soma Biswas

Active Director Director DIN 07579607
DIN 07579607 First appointment Aug 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2016
Shareholding value •••• Premium profile

About Soma Biswas

Data last updated:

Soma Biswas is a Director at Alienus Pharmaceutical Private Limited (since 2016). The company operates in Pharma. Alienus Pharmaceutical Private Limited reported revenue of ₹2.5 Lakh (FY 2019).

DIN 07579607
Primary Designation Director
Industry Pharma
First Appointment 02 Aug 2016
Oldest Company Age 11 yrs
Largest company Alienus Pharmaceutical Private Limited · ₹2.5 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Aug 20162015₹2.5 Lakh (FY 2019)Active

Board colleagues of Soma Biswas

NameDINCompanyDesignation
Bikramjit Das07069016Alienus Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alienus Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Soma Biswas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Soma Biswas

Soma Biswas currently holds 1 directorship: Alienus Pharmaceutical Private Limited (Director, since 02 Aug 2016, revenue ₹2.5 Lakh (FY 2019)).

Soma Biswas was first appointed on 02 Aug 2016 as Director at Alienus Pharmaceutical Private Limited.

The current boards of Soma Biswas's companies include Bikramjit Das (Alienus Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available